Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

66.50 -0.76 (-1.13%)
Streaming Delayed Price Updated: 12:19 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Edwards Lifesciences

Edwards Lifesciences Completes Sale of Critical Care
From Edwards Lifesciences Corporation
Via Business Wire
CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
From Edwards Lifesciences Corporation
Via Business Wire
Watch for Continued Gains in Shares of Edwards Lifesciences Corporation (EW)
Via Investor Brand Network
Edwards Lifesciences Reports Second Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Acquire Innovalve
From Edwards Lifesciences Corporation
Via Business Wire
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Sell Critical Care to BD
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
From Edwards Lifesciences Corporation
Via Business Wire
The 5 Stocks Most Sold By Insiders This Year
Insiders are selling these 5 stocks increased as their markets advanced, and gains may be capped. Long-term outlooks are positive for growth and share prices. 
Via MarketBeat
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
From Edwards Lifesciences Corporation
Via Business Wire
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Can financial, healthcare, energy stocks rise as rates stay high?
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024. 
Via MarketBeat
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
From Edwards Lifesciences Corporation
Via Business Wire
Patients With Deadly Heart Disease Underdiagnosed, Including 66% of Women: AI-Powered Clinical Study Shows
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Analysts Say GE's Healthcare Spinoff Has $20 Upside
General Electric’s spinoff, GE HealthCare Technologies Inc., is delivering some impressive results and has growth opportunities well worth tuning in to. 
Via MarketBeat
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Edwards Life Sciences Stock Disaster Could Be Your Bounty
Heart disease equipment maker Edwards Life Sciences (NYSE: EW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report. 
Via MarketBeat
Topics Death
Exposures COVID-19 Death
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand
Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary – The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the... 
Via FinancialNewsMedia
Topics Death Economy
Exposures Death Economy
Edwards Lifesciences Corp. (EW) Looks to Continue to Trade Above its Annual-High Share Price Today
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.